comparemela.com
Home
Live Updates
RGLS stock surges after Phase 1 data for kidney disease can
RGLS stock surges after Phase 1 data for kidney disease can
RGLS stock surges after Phase 1 data for kidney disease candidate (NASDAQ:RGLS)
The shares of clinical-stage biotech Regulus Therapeutics Inc
Related Keywords
Bret Jensen ,
Regulus Therapeutics Inc ,
Nasdaq ,
Regulus Therapeutics ,
Ascending Dose ,
Autosomal Dominant Polycystic Kidney Disease ,
Multiple Ascending Dose ,
Seeking Alpha ,